
Pulmonary hypertension zzso is a progressive disease of the pulmonary zzso characterized by increased vascular resistance and pressure overload of the right zzso zzso zzso lungs demonstrate zzso zzso of small pulmonary arteries and proliferation of zzso cells resulting in zzso zzso Recent studies have identified zzso of the bone zzso protein zzso 2 zzso gene and the zzso zzso 1 zzso zzso that affect the transforming growth factor beta zzso zzso zzso a group of zzso signaling molecules with zzso zzso activity that are involved in the regulation of cell zzso Several lines of evidence indicate that the development of zzso is a zzso process, where one of the events is having a gene zzso and another might be a circumstantial condition or other zzso zzso It is unknown which mechanism that is critical in rheumatic diseases causes pulmonary vascular zzso zzso is most frequently associated with systemic sclerosis zzso systemic lupus zzso zzso and mixed zzso tissue disease zzso however, it is still a rare manifestation of these zzso For example, approximately zzso of SS cases manifest pulmonary vascular zzso In recent years symptomatic zzso therapies have been employed and have been able to improve exercise capacity and survival in these zzso 

